| Literature DB >> 29958800 |
Yuki Morimoto1, Kiyoshi Hirahara2, Masahiro Kiuchi3, Tomoko Wada3, Tomomi Ichikawa3, Toshio Kanno3, Mikiko Okano3, Kota Kokubo3, Atsushi Onodera4, Daiju Sakurai5, Yoshitaka Okamoto5, Toshinori Nakayama6.
Abstract
Memory T cells provide long-lasting protective immunity, and distinct subpopulations of memory T cells drive chronic inflammatory diseases such as asthma. Asthma is a chronic allergic inflammatory disease with airway remodeling including fibrotic changes. The immunological mechanisms that induce airway fibrotic changes remain unknown. We found that interleukin-33 (IL-33) enhanced amphiregulin production by the IL-33 receptor, ST2hi memory T helper 2 (Th2) cells. Amphiregulin-epidermal growth factor receptor (EGFR)-mediated signaling directly reprogramed eosinophils to an inflammatory state with enhanced production of osteopontin, a key profibrotic immunomodulatory protein. IL-5-producing memory Th2 cells and amphiregulin-producing memory Th2 cells appeared to cooperate to establish lung fibrosis. The analysis of polyps from patients with eosinophilic chronic rhinosinusitis revealed fibrosis with accumulation of amphiregulin-producing CRTH2hiCD161hiCD45RO+CD4+ Th2 cells and osteopontin-producing eosinophils. Thus, the IL-33-amphiregulin-osteopontin axis directs fibrotic responses in eosinophilic airway inflammation and is a potential target for the treatment of fibrosis induced by chronic allergic disorders.Entities:
Keywords: ECRS; EGFR; IL-33; airway fibrosis; amphiregulin; eosinophil; osteopontin; pathogenic memory Th2 cells
Mesh:
Substances:
Year: 2018 PMID: 29958800 DOI: 10.1016/j.immuni.2018.04.023
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745